Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Department of Medical Oncology, Gustave Roussy

1 abstract

Abstract
Immune landscape of patients with metastatic non-clear cell renal cell carcinoma (nccRCC) treated with atezolizumab plus bevacizumab.
Org: Dana-Farber Cancer Institute, Dana-Farber Cancer Institute and Harvard Medical School, Brigham and Women's Hospital/Massachusetts General Hospital, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, Department of Medical Oncology, Gustave Roussy,